Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial.
暂无分享，去创建一个
C. Sotiriou | F. Cardoso | D. Zardavas | M. Piccart-Gebhart | M. Paesmans | V. D’Hondt | A. Awada | E. de Azambuja | T. Gil | D. Devriendt | F. Lebrun | M. Lemort | Y. Lalami | J. Rossari | A. Buttice | C. Moulin | V. D'Hondt